Insufflation of Carbon Dioxide During Cardiac Surgery as Prevention Neurologic Complications
NCT ID: NCT02340741
Last Updated: 2016-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
334 participants
INTERVENTIONAL
2014-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modulation of Microbiota Metabolism in Cardiac Surgery Patients
NCT04921436
Outcomes After Perioperative Stroke Following Cardiac Surgery
NCT05333146
Effect of Remote Ischemic Preconditioning on Cognitive Function After Cardiac Surgery
NCT00877305
Biochemical Predictors of Delirium in Cardiac Surgery
NCT03931499
Prevalence of Delirium in Patients Undergoing Cardiac Surgery
NCT00242151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Carbon dioxide fills the thoracic cavity by gravity and replaces air if adequately insufflated. Because solubility of CO2 is better than that of air, occlusion or flow disruption in arteries of the brain or the heart is thought to be diminished. Despite carefully performed deairing procedures as puncturing of the ascending aorta and cardiac massage, transcranial Doppler studies revealed large amounts of emboli during the first ejections of the beating heart (van der Linden J et al. 1991). In patiens with minimally invasive approach and redo valve surgery, deairing of the cardiac chambers has become more difficult.
Although the use of carbon dioxide when filling in the surgical field, as the prevention of air embolism reduces the number of intracardiac emboli according to transesophageal echocardiography there is no evidence of a sustained reduction in cerebrovascular events (G. Salvatore al. 2009).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
conventional prophylaxis of aeroembolism
Procedure: cardiac surgery with opening of heart chambers.
Will be including 167 patients to undergo cardiac surgery. After the main operation phase all heart cavities are sealed, left vent drainage is stopped, ascending aorta is punctured and cardiac massage is performed, ventilation is started and the heart is filled with volume. Operating table is positioned in the Trendelenburg position, and aorta is opened. The amount of air in the cavities is evaluated by transesophageal echocardiography.
conventional prophylaxis of aeroembolism
167 patients will be enrolled. Will perform standard way of aeroembolism prevention
cardiac surgery with opening of heart chambers
Patients with different clinical diagnoses, which is planned to cardiac surgery with the opening heart cavities
conventional prophylaxis plus CO2 insufflation
Procedure: cardiac surgery with opening of heart chambers.
Will be including 167 patients to undergo cardiac surgery. After the main phase of the operation standard measures of aeroembolism prevention are carried out. The amount of air in the cavities is evaluated by transesophageal echocardiography.
conventional prophylaxis plus CO2 insufflation
167 patients will be enrolled. Will perform standard way of aeroembolism prevention and insufflation of carbon dioxide
cardiac surgery with opening of heart chambers
Patients with different clinical diagnoses, which is planned to cardiac surgery with the opening heart cavities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
conventional prophylaxis of aeroembolism
167 patients will be enrolled. Will perform standard way of aeroembolism prevention
conventional prophylaxis plus CO2 insufflation
167 patients will be enrolled. Will perform standard way of aeroembolism prevention and insufflation of carbon dioxide
cardiac surgery with opening of heart chambers
Patients with different clinical diagnoses, which is planned to cardiac surgery with the opening heart cavities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 70 years
* Patients scheduled on cardiac surgery with opening cavities
Exclusion Criteria
* Significant carotid artery stenosis
* Presence of initial severe encephalopathy
* Re-clamping of the aorta
* Emergency surgery
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meshalkin Research Institute of Pathology of Circulation
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aleksandr V Bogachev-Prokophiev, PhD
Role: PRINCIPAL_INVESTIGATOR
Meshalkin Research Institute of Pathology of Circulation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novosibirsk State Research Institute of Circulation Pathology
Novosibirsk, Novosibirsk Territory, Russia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-54-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.